TET2 and pulmonary arterial hypertension: For methylomic measurements, we used blood samples previously extracted from our published cohorts of patients with PAH and a TET2 mutation (n = 9), or PAH without mutations of TET2 (n = 10) versus healthy controls (n = 10) (Potus et al. 2020) (Figure 1A,B).